Treatment of advanced alcoholic liver disease.
The poor prognosis of severe acute alcoholic hepatitis has stimulated interest in specific forms of treatment aimed at reducing the short term mortality as well as preventing progression to cirrhosis. Several controlled trials of steroid therapy have suggested an improvement in short-term survival, but the benefit seems to apply to highly selected cases only. Treatment with propylthiouracil and insulin and glucagon infusions has also shown promising results in controlled studies but there is still no general agreement on their value. Despite recent interest in the use of colchicine to prevent progression of cirrhosis in chronic liver disease of other aetiologies, its role in alcoholic liver disease is not yet clear. In end-stage alcoholic cirrhosis, excellent results are now being achieved with liver transplantation, although this is limited to patients who are not alcohol dependent and in whom there is no alcohol-induced extrahepatic disease.
Bird
G L
GL
Liver Unit, King's College Hospital, Denmark Hill, London, U.K.
Williams
R
R
D000596:Amino Acids / Q000008:administration & dosage; D045930:Anabolic Agents / Q000008:administration & dosage; D003078:Colchicine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006501:Hepatic Encephalopathy / Q000628:therapy; D006519:Hepatitis, Alcoholic / Q000628:therapy*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000628:therapy*; D016031:Liver Transplantation / Q000379:methods; D011239:Prednisolone / Q000008:administration & dosage; D011441:Propylthiouracil / Q000008:administration & dosage
D000596:Amino Acids; D045930:Anabolic Agents; D011441:Propylthiouracil; D011239:Prednisolone; D003078:Colchicine